Wolfgang Dummer - 02 Feb 2023 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Reporting relationship: EVP & CMO
Issuer ticker: RIGL
Reported as of: 02 Feb 2023
Net transaction value: -$8,946
SEC form: 4
Accepted by SEC: 06 Feb 2023, 16:40:17 UTC
Prior SEC filing: 30 Jan 2023
Next SEC filing: 04 Oct 2023
Source filing: View source filing
Reporting owner signature: /s/ Raymond Furey (Attorney-in-Fact)

Key filing fact

Wolfgang Dummer filed Form 4 for RIGEL PHARMACEUTICALS INC (RIGL) on 06 Feb 2023.

Key facts

This page summarizes Wolfgang Dummer's Form 4 filing for RIGEL PHARMACEUTICALS INC (RIGL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Feb 2023, 16:40.

Change

Previous filing in this sequence was filed on 30 Jan 2023.
Current net transaction value: -$8,946.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RIGL transaction

Common Stock

Sale

Transaction value: $8,946
Shares: -5,389
Change %: -6.9%
Price: $1.66
Shares after: 72,459
Date: 02 Feb 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.

Footnote F2

Includes 10,000 shares acquired under the Issuer's stock purchase plan.